Tony Serafini-Lamanna
Executive VP-Diagnostics, Meridian Bioscience.
Companies
- Meridian BioscienceExecutive VP-Diagnostics May 21, 2020 to Jan 31, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Meridian Bioscience0 shares2Jan 31, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 31, 2023Returned to company 43,338 shares of Meridian Bioscience2
- Jan 31, 2023Granted 7,945 shares of Meridian Bioscience2
- Nov 15, 2022Shares withheld for tax 3,666 shares at $31.83 of Meridian Bioscience3
- Nov 4, 2022Shares withheld for tax 788 shares at $32.01 of Meridian Bioscience4
- Sep 16, 2022Shares withheld for tax 357 shares at $32.14 of Meridian Bioscience5
- Nov 15, 2021Granted 24,343 shares of Meridian Bioscience6
- Nov 15, 2021Shares withheld for tax 2,232 shares at $20.16 of Meridian Bioscience7
- Nov 15, 2021Other 24,343 shares of Meridian Bioscience6
- Nov 4, 2021Granted 10,593 shares of Meridian Bioscience8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Nov 17, 2022
- 4SEC EDGARForm 4 filed Nov 8, 2022
- 5SEC EDGARForm 4 filed Oct 5, 2022
- 6SEC EDGARForm 4 filed Nov 16, 2021
- 7SEC EDGARForm 4 filed Dec 16, 2021
- 8SEC EDGARForm 4 filed Nov 8, 2021